Psychedelic substances are increasingly being used under medical supervision to treat anxiety disorders and depression. However, the mechanisms by which these substances influence our perception and consciousness are largely unknown. A research team from Hong Kong, Singapore, and Ruhr University Bochum, Germany, has now, for the first time, shown high-resolution images of brain activities in an animal model after the administration of psychedelics. The scientists discovered that visual processes increasingly access brain regions that retrieve memory contents and associations. This could explain how visual hallucinations arise. The scientists report in Communications Biology on February 11, 2026.

Psychedelics activate a specific serotonin receptor. At least 14 different receptors are known where the neurotransmitter serotonin binds. Psychedelics have the highest affinity for the 2A receptor, which, among other effects, acts suppressive in the visual brain and also influences learning processes. “We have observed in earlier studies that visual processes in the brain are suppressed by this receptor,” says Callum White, first author of the study. “This means that visual information about things happening in the outside world becomes less accessible to our consciousness. To fill this gap in the puzzle, our brain inserts fragments from memory – it hallucinates.”

In their current study, the authors show how this happens. Psychedelics intensify oscillations in visual brain areas. Generally speaking, oscillations are synchronized neural activity waves that modulate communication between brain regions. After administration of psychedelics the scientist found that visual areas produce increasingly low-frequency (5-Hz) activity waves that activate another brain region, the retrosplenial cortex. This area forms a major hub for the exchange with stored information. The brain thus switches to a new mode in which access to ongoing events is hindered and instead perceptions are increasingly generated from memory contents, “a bit like partial dreaming,” says Professor Dirk Jancke, leader of the study.

To visualize these complex processes, the scientists use an optical method that records neural activity in real-time over the entire brain surface. The mice developed by Professor Thomas Knöpfel from Hong Kong Baptist University are genetically manipulated so that they express fluorescent proteins in defined cell types. “We therefore know exactly in our experiments that the measured fluorescent signals originate from pyramidal cells of the cortical layers 2/3 and 5, which mediate communication within and between brain regions,” says Jancke.

The results support new approaches in psychology that use psychedelics to treat, for example, anxiety disorders or depression. “When used under medical supervision, such substances can temporarily change the state of the brain to selectively recall positive memory content and restructure learned, excessively negative thought patterns, i.e., to be able to unlearn negative context. It will be exciting to see how such therapies are further personalized in the future,” says Jancke.